Gummy Candies With Maqui Berry (NCT07373795) | Clinical Trial Compass
CompletedNot Applicable
Gummy Candies With Maqui Berry
Chile10 participantsStarted 2025-12-02
Plain-language summary
The goal of this clinical trial is to learn if Maqui berry gummy encapsulated (GMM) compared to non-encapsulated (GM) can improve glycemic response in overweight adults. It will also learn about the possible effect of serum antioxidant levels. The main questions it aims to answer are:
Does GMM or GM low the glycemic response in overweight/obese subjects after consuming a carbohydrate rich food?
Does GMM or GM increase antioxidant levels in overweight/obese subjects after consuming a carbohydrate rich food?
Researchers will compare (i) a carbohydrate rich food, (ii) GMM + a carbohydrate rich food, (iii) GM + a carbohydrate rich food to see if Maqui gummy work to control glycemic and antioxidant levels.
Participants will:
Take a carbohydrate rich food, and/or Maqui gummy three times, one week apart Have blood samples collected and answer food questionnaires in each visit
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Body mass index (BMI) of overweight or obesity (BMI at least 25.0 kg/m2);
* absence of non-communicable chronic disease;
* being sedentary (less than 30 minutes of physical activity for 3 times a week).
* All participants must maintain their physical activity, food intake and medications during the whole study.
Exclusion Criteria:
* use of hypoglycemic drugs
* supplements containing antioxidants
* high consumption of polyphenols (more than 2 g per day)
* food allergy to Maqui berry or any component from the GCs
* pregnancy or lactation in the case of the female participants
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Glycemia
Timeframe: Blood capillary samples will be obtained from participant's finger using glucose test strips (One Touch II) before consuming the white bread (time 0) and after consumption with or without the GCs (at 15, 30, 60, 90 and 120 minutes).